Nutriband Inc. income statement NTRB

Annual Quarterly

In fiscal 2026, which ended Jan 31, 2026, Nutriband Inc. reported revenue of $2.0 million, down 4.8% from the year before. It recorded a net loss of $8.2 million. The operating loss came to $8.3 million, an operating margin of -408.4%. Diluted earnings per share were -$2.58. Over the twelve months ended Jul 31, 2026, revenue was $1.6 million and the net loss was $7.0 million. Across the 8 fiscal years shown, revenue grew from $245,285 in fiscal 2019 to $2.0 million in fiscal 2026, about 35.3% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2027 Jul 31, 2026	FY 2026 Jan 31, 2026	FY 2025 Jan 31, 2025	FY 2024 Jan 31, 2024	FY 2023 Jan 31, 2023	FY 2022 Jan 31, 2022	FY 2021 Jan 31, 2021	FY 2020 Jan 31, 2020	FY 2019 Jan 31, 2019	FY 2018 Jan 31, 2018	FY 2017 Jan 31, 2017
Revenue	2	2 -4.8%	2 +2.6%	2 +0.3%	2 +76.3%	1 +25.0%	1 +154.6%	0 +51.1%	0	—	—
Cost of revenue	1	1 +5.3%	1 +14.1%	1 -8.0%	1 +44.8%	1 +46.3%	1 +14.3%	1 +90.5%	0	—	—
Gross profit	1	1 -23.8%	1 -13.8%	1 +14.9%	1 +35.4%	1 +75.2%	0 +277.3%	-0 -314.9%	-0	—	—
Research and development	1	2 -39.4%	3 +59.1%	2 +99.6%	1 +138.8%	0	—	—	—	—	—
Selling, general and administrative	6	7 +62.1%	4 +14.3%	4 -3.6%	4 -2.7%	4 +38.1%	3 +62.6%	2 -45.5%	3 +1812.4%	0 +13.7%	0
Operating expenses	8	9	—	6	—	—	3 +62.6%	2	—	—	—
Operating income	-7	-8 +19.1%	-10 -111.1%	-5 -8.9%	-4 +26.8%	-6 -135.4%	-3 -31.8%	-2	—	-3 -1666.5%	-0
Interest income	0	0 -42.2%	0	—	—	—	—	—	—	—	—
Interest expense	0	0 +5.3%	0	—	—	—	—	—	—	—	—
Pretax income	-7	-8 +21.5%	-10 -91.1%	-5 -22.3%	-4 +27.4%	-6 -110.6%	-3 -7.8%	-3 +18.3%	-3	—	—
Net income	-7	-8 +21.5%	-10 -91.1%	-5 -22.3%	-4 +27.4%	-6 -110.6%	-3 -7.8%	-3 +18.3%	-3 -24.7%	-3 -1666.5%	-0
Net income to common	-7	-30	—	—	-4	—	—	—	—	—	—
Basic EPS	-0.57	-2.58 -160.6%	-0.99 -43.5%	-0.69 -30.2%	-0.53 +33.8%	-0.80	—	—	—	—	—
Diluted EPS	-0.57	-2.58 -160.6%	-0.99 -43.5%	-0.69 -30.2%	-0.53	—	—	—	—	—	—
Weighted average shares, basic	12	12 +9.7%	11 +33.4%	8 -6.0%	8	—	—	—	—	—	—
Weighted average shares, diluted	12	12 +9.7%	11 +33.4%	8 -6.0%	8 +6.6%	8	—	—	—	—	—
Other measures
Depreciation and amortization	0	0 -32.0%	0 -0.9%	0 -12.8%	0 +6.9%	0 +92.8%	0 +121.8%	0 +95.0%	0	—	—
EBITDA	-7	-8 +18.8%	-10 -118.1%	-5 -10.6%	-4 +28.6%	-6 -138.2%	-2 -28.4%	-2	—	—	—
Interest coverage	-339.35x	-369.11x	-480.44x	—	—	—	—	—	—	—	—
Margins
Gross margin	33.14%	27.81%	34.74%	41.34%	36.08%	46.99%	33.52%	-48.15%	-17.54%	—	—
Operating margin	-435.58%	-408.41%	-480.70%	-233.63%	-215.18%	-518.03%	-275.08%	-531.35%	—	—	—
Pretax margin	-430.43%	-404.08%	-489.95%	-263.04%	-215.58%	-523.57%	-310.78%	-734.29%	-1,358.11%	—	—
Profit margin	-430.43%	-404.08%	-489.95%	-263.04%	-215.58%	-523.57%	-310.78%	-734.29%	-1,358.11%	—	—
EBITDA margin	-426.52%	-398.90%	-467.38%	-219.83%	-199.31%	-491.85%	-258.12%	-511.88%	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as: NTRB (Nasdaq)
Fiscal year ends: January 31
Incorporated in: NV
Headquarters: Orlando, FL
SEC filer status: , Emerging growth company
SEC CIK: 1676047

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.